Gaurav Shah - May 17, 2023 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role
CEO, Director
Signature
/s/ Martin Wilson, as attorney-in-fact for Gaurav Shah
Stock symbol
RCKT
Transactions as of
May 17, 2023
Transactions value $
-$88,108
Form type
4
Date filed
5/19/2023, 04:05 PM
Previous filing
May 16, 2023
Next filing
Jun 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RCKT Common Stock Sale -$88.1K -4.12K -0.78% $21.38 522K May 17, 2023 Direct F1
holding RCKT Common Stock 208K May 17, 2023 By Spouse
holding RCKT Common Stock 198K May 17, 2023 By Gaurav D. Shah Irrevocable Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) received by the Reporting Person.